Vasopressin NDC 68083-663

NDC codes

FDA NDC Directory

Product NDC (as listed)68083-663Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68083-0663Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68083-663-10	68083066310	10 VIAL in 1 CARTON (68083-663-10) / 100 mL in 1 VIALMarketed from Aug 22, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vasopressin
Generic name (nonproprietary): vasopressin
Active ingredients: Vasopressin — .4 [USP'U]/mL
Dosage form: Injection
Route: Intravenous
Labeler: Gland Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216963
Marketing start: Aug 22, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Diuresis (Physiologic effect)Vasoconstriction (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 68083-663_d8e752a0-dc4e-4262-921f-133a88d89db8SPL ID d8e752a0-dc4e-4262-921f-133a88d89db8SPL set ID 971f9b1c-6094-4f80-920b-cb5d7e62950aRxCUI 2103182, 2399907UNII Y4907O6MFD

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468083066310 followed by a unit qualifier and the quantity

Package 68083-0663-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 26, 2025.

Indications (excerpt from the label)

Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. • Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216963

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216963
Product	Strength	Form · route	Labeler	Product NDC
Vasopressin	Vasopressin 20 [USP'U]/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-474
Vasopressin	Vasopressin 20 [USP'U]/mL	InjectionIntravenous	Gland Pharma Limited	68083-520